ETR:AFX Carl Zeiss Meditec (AFX) Stock Price, News & Analysis €30.50 +0.08 (+0.26%) As of 07/31/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Carl Zeiss Meditec Stock (ETR:AFX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Carl Zeiss Meditec alerts:Sign Up Key Stats Today's Range€30.50▼€31.5250-Day Range€24.80▼€31.5652-Week Range€54.60▼€123.75Volume279,989 shsAverage Volume94,405 shsMarket Capitalization€2.84 billionP/E Ratio16.30Dividend Yield1.80%Price TargetN/AConsensus RatingN/A Company Overview Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG. Read More Receive AFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AFX Stock News HeadlinesCarl Zeiss Meditec AG: ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 UnitsJune 18, 2026 | finanznachrichten.deEarnings Miss: Carl Zeiss Meditec AG Missed EPS And Analysts Are Revising Their ForecastsMay 15, 2026 | finance.yahoo.com[URGENT] Mode Mobile terms changing Aug 14Mode Mobile has secured its Nasdaq ticker, $MODE, while still in the pre-IPO stage. More than 60,000 investors have already put over $100 million into the company, including original Shark Tank investor Kevin Harrington. The company reports 490M+ users, $115M+ in lifetime revenue, and $1B+ earned and saved by users across 170+ countries. Deloitte ranked Mode North America's #1 fastest-growing software company in 2023 after 32,481% growth. Pre-IPO shares are currently priced at 0.52 dollars, but that price is set to change on August 14. | Mode Mobile (Ad)Has Carl Zeiss Meditec (XTRA:AFX) Fallen Too Far After Recent Medtech Reassessment?February 25, 2026 | finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last YearJanuary 28, 2026 | finance.yahoo.comBernstein downgrades Carl Zeiss Meditec stock rating amid profit warningJanuary 27, 2026 | investing.comCarl Zeiss Meditec shares sink on profit warningJanuary 22, 2026 | uk.finance.yahoo.comCarl Zeiss Meditec (ETR:AFX) Is Reducing Its Dividend To €0.55January 10, 2026 | finance.yahoo.comSee More Headlines AFX Stock Analysis - Frequently Asked Questions How have AFX shares performed this year? Carl Zeiss Meditec's stock was trading at €40.00 at the beginning of the year. Since then, AFX shares have decreased by 23.8% and is now trading at €30.50. What other stocks do shareholders of Carl Zeiss Meditec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE). Industry, Sector and Symbol Stock ExchangeETR SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolETR:AFX CIKN/A Webwww.zeiss.com Phone+49-3641-2200FaxN/AEmployees4,950Year FoundedN/AProfitability EPS (Trailing Twelve Months)€1.87 Trailing P/E Ratio16.30 Forward P/E Ratio10.44 P/E Growth2.83Net Income€185.59 million Net Margins3.41% Pretax MarginN/A Return on Equity4.27% Return on Assets7.03% Debt Debt-to-Equity Ratio29.43 Current Ratio2.43 Quick Ratio2.47 Sales & Book Value Annual Sales€2.64 billion Price / Sales1.08 Cash Flow€0.02 per share Price / Cash Flow1,398.28 Book Value€24.08 per share Price / Book1.27Miscellaneous Outstanding Shares93,178,085Free FloatN/AMarket Cap€2.84 billion OptionableNot Optionable Beta1.34 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (ETR:AFX) was last updated on 8/2/2026 by MarketBeat.com Staff. From Our PartnersOne signature away. Expected within months.On May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on Am...Behind the Markets | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredAmerica Is Following in Greece's FootstepsItaly in the 90s. Argentina in 2001. Greece in 2009. America was always safe… But now the IMF is projecting th...Decentralized Masters | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Carl Zeiss Meditec With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
